NCT06711718

Brief Summary

This study aims to evaluate the clinical utility and acceptability to patients and practitioners of running diabetes classification algorithms on primary care data to help improve diagnosis of diabetes subtypes in adults diagnosed with diabetes under the age of 50. The outputs from this research will help provide initial data on how best to use these algorithms in primary care and the optimal design of a decision support tool that could be taken forward to a full trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 25, 2024

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

July 4, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

December 2, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2026

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

1.7 years

First QC Date

July 4, 2024

Last Update Submit

April 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number and Proportion of patients flagged by the tool

    Number and Proportion of patients flagged by the tool at each practice. Mean number of patients flagged by the tool across the practices.

    Months 12-18.

Secondary Outcomes (1)

  • Assessment of acceptability of the DePICtion Tool

    Interviews to be conducted from 2 weeks to 6 months after implementing the tool in practice.

Study Arms (2)

Patients qualitative interviews

1. Patients reviewed by their GP as a result of Stage 1 (running of tool) are invited to a qualitative interview. 2. Consenting participants interviewed by the research team. 3. Information used to assess the impact and potential benefit of using the diabetes classification tool in general practice.

Other: Qualitative interview (patients)

Practice staff qualitative interviews

1. Practice staff (clinical and administrative) who have been involved in Stage 1 (running of tool) are invited to a qualitative interview. 2. Consenting participants interviewed by the research team. 3. Information used to assess the impact and potential benefit of using the diabetes classification tool in general practice.

Other: Qualitative interview (staff)

Interventions

Qualitative interviews to be carried out by an experienced researcher with patients who have had their diabetes diagnosis reviewed as a result of the running of the tool.

Patients qualitative interviews

Qualitative interviews to be carried out by an experienced researcher with practice staff who have run the tool and reviewed patients flagged by the tool.

Practice staff qualitative interviews

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have had a review of their diabetes diagnosis as a result of the running of the tool will be invited to interview. Clinical practice staff (GP and/or nurse) who have been involved in reviewing patients flagged following running of the tool will be invited to interview. Practice Manager or administrator who has run the searches and tool will be invited to interview.

You may qualify if:

  • Patients
  • Able to give written informed consent
  • years of age or over at the time of study participation
  • Diabetes diagnosed at or under the age of 50
  • Registered with a participating GP practice
  • Sufficient understanding of the English Language to enable completion of the interview
  • Staff
  • Able to give written informed consent
  • years of age or over
  • Working at a participating General Practice and directly involved with the study procedures (eg running the decision support tool, responsibility for clinical care of diabetes patients)

You may not qualify if:

  • Patients
  • Unable to give written informed consent
  • Under 18 years of age
  • No diabetes or diabetes diagnosed over the age of 50.
  • Not registered with a participating GP practice
  • Insufficient understanding of the English Language to enable interview completion
  • Have an opt-out code where patient has declined electronic medical records examined
  • Considered by their General Practitioner(s) to be inappropriate to recruit due to psycho-social reasons, participating in another related clinical trial or significant health reasons, e.g. terminal illness/diagnosis.
  • Staff
  • Unable to give written informed consent
  • Under 18 years of age
  • General Practice staff not involved with the study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Tamar Valley Health

Plymouth, Cornwall, PL17 7AW, United Kingdom

Location

Ivybridge Medical Practice (Beacon Medical Group)

Ivybridge, Devon, PL21 0AJ, United Kingdom

Location

Roborough Surgery

Plymouth, Devon, PL6 6PH, United Kingdom

Location

Pathfields Medical Group

Plymouth, Devon, PL7 1AD, United Kingdom

Location

Plympton Health Centre (Beacon Medical Group)

Plymouth, Devon, PL7 1AD, United Kingdom

Location

Chaddlewood Surgery (Beacon Medical Group)

Plymouth, Devon, PL7 2QP, United Kingdom

Location

Hucknall Road Medical Centre

Nottingham, Nottinghamshire, NG5 1NA, United Kingdom

Location

Parkside Medical Practice

Nottingham, Nottinghamshire, NG6 8QJ, United Kingdom

Location

Chilwell Valley and Meadows Practice

Nottingham, Nottinghamshire, NG9 6DX, United Kingdom

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Beverley Shields, Professor

    University of Exeter

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2024

First Posted

December 2, 2024

Study Start

June 25, 2024

Primary Completion

March 5, 2026

Study Completion

March 31, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04

Locations